Strategic research on the AT₂concept is conducted in collaboration with Professor Thomas Unger atCenter for Cardiovascular Research (CCR),athttp://www.ccr.charite.de/site/html/de/home.html

Charité Hospital in Berlin, Germany. Professor Unger and his group of researchers have developed the pre-clinical plan for cardiovascular indications for the company’s candidate drug.  At CCR there is considerable experience with drug development related research from drug development projects with both large and small pharmaceutical industries.

Sahlgrenska Academy
http://www.sahlgrenska.gu.se/

is the medical research and teaching part of Göteborg University. Vicore Pharma collaborates closely with relevant researchers within the faculty.

Uppsala University and Medicinal Chemistry Department
http://www.orgfarm.uu.se

The substances developed in Vicore Pharma have been developed and synthesized at the Medicinal Chemistry Department at Uppsala University under the guidance of Professor Anders Hallberg who also holds the Dean’s chair at this prestigious university.